Quantum Biopharma (QNTM) Short-Term Debt issuances (2022 - 2025)
Quantum Biopharma recorded quarterly Short-Term Debt issuances of -$2.5 million in Q1 2025, down 73.64% quarter-over-quarter from -$1.4 million in Q1 2024, and down 73.64% year-over-year from -$9.4 million in Q1 2024.
Quantum Biopharma's Short-Term Debt issuances history runs 4 years deep, the most recent figure standing at -$2.5 million for Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -33,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.48 Mn |
| Mar 31, 2025 | -2.48 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Jun 30, 2023 | -3.55 Mn |
| Jun 30, 2023 | -3.55 Mn |
| Mar 31, 2023 | -7.76 Mn |
| Mar 31, 2023 | -7.76 Mn |
| Sep 30, 2022 | 7.87 Mn |
| Sep 30, 2022 | 7.87 Mn |
| Jun 30, 2022 | -3.05 Mn |
| Jun 30, 2022 | -3.05 Mn |
| Mar 31, 2022 | 6.69 Mn |
| Mar 31, 2022 | 6.69 Mn |